GlassScriptPhysician profile
Julia Pleet Binder
NPI 1831483015
$1,400.32
in general payments reported to CMS, 2019-2025
13 companies · $316 in 2025
The $316 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $103 · 2021: $220 · 2022: $129 · 2023: $193 · 2024: $438 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $948.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $947.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $323.80 | 2021-2024 | Zeposia |
| Janssen Scientific Affairs, LLC | $242.59 | 2024-2025 | Tremfya |
| Abbvie INC. | $192.14 | 2021-2025 | Skyrizi, Rinvoq |
| Genzyme Corporation | $122.34 | 2025 | |
| Intercept Pharmaceuticals, INC. | $115.64 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $103.13 | 2020 | |
| Lilly USA, LLC | $94.08 | 2023-2025 | Omvoh |
| Janssen Biotech, INC. | $62.69 | 2022-2025 | Tremfya |
| Braintree Laboratories, INC. | $43.27 | 2021 | |
| Amgen INC. | $33.23 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.32 | 2021 | |
| Boston Scientific Corporation | $22.91 | 2022 | |
| Ardelyx, INC. | $13.18 | 2024 | Ibsrela |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Binder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.